Fred Hutchinson Cancer Center clinical trial pipeline
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-19
What changed in the last 30 days
22 trials changed in the last 30 days: 0 stopped, 13 with notable changes, 9 with minor changes only.
- Notable: IL-18 Armored STEAP1 CAR T Cells · Metastatic Castration Resistant Prostate Cancer Start date pushed from Oct 31, 2026 to Dec 31, 2026
- Notable: Tele-HOPE · Telehealth Pharmacist Opioid Patient Education Pilot Study Recruitment opened
- Notable: Educational Intervention (Lung Toolkit) for Improving Knowledge About Lung Cancer and Screening Among American Indian and Alaskan Native Cigarette Smokers, Lung PATHS Trial Start date pushed from Nov 1, 2026 to Dec 1, 2026
- Minor: One vs Two Probes for Thermal Ablation Among Cervical Cancer Screen Positive Women Living With HIV in C1001P-CS7 Zimbabwe Study completion pushed from Dec 31, 2027 to May 31, 2028
- Minor: One vs Two Probes for TA Among Cervical Cancer Screen Positive WLWH in C1001P-CS5 Rwanda Study completion pushed from Dec 31, 2027 to May 31, 2028
- Notable: Estrogen to Improve Quality of Life · Newly Diagnosed or Recurrent Metastatic Hormone Sensitive Prostate Cancer, EQUIP Trial Start date pushed from Nov 1, 2026 to Dec 1, 2026
- Notable: ICanQuit Smoking Cessation Among Hispanic Adults Start date pushed from Oct 15, 2026 to Dec 1, 2026
- Notable: Nemtabrutinib and Lisocabtagene Maraleucel · Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Start date pushed from Oct 15, 2026 to Dec 1, 2026
- Notable: FH-WT1-E50 TCR T Cells With Azacitidine · Minimal Residual Disease Positive Acute Myeloid Leukemia Start date pushed from Oct 15, 2026 to Dec 1, 2026
- Notable: Interpersonal Communication Training and Vaccination Workflow Training Alone and in Combination to Improve Communication and Recommendations About HPV Vaccination in Pharmacies, IMPACT HPV Trial Start date pushed from Oct 15, 2026 to Dec 1, 2026
- Notable: Restorative Justice-Based Lung Cancer Screening Decision-Making Support Intervention Tailored for Black Individuals to Increase Lung Cancer Screening Among Black Community Members, RESTORE Trial Start date pushed from Oct 15, 2026 to Dec 1, 2026
- Minor: Tailored Patient Navigation to Improve the Uptake of Lung Cancer Screening in Tribal Communities in Western Washington State, SACRED LUNGS Trial Start date changed from estimate of Oct 15, 2026 to Oct 1, 2026
- Minor: Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation · High-Risk Hematologic Diseases Interventions modified
- Minor: Enfortumab Vedotin, Pembrolizumab and Quemliclustat · Unresectable Locally Advanced and Metastatic Urothelial Cancer Start date changed from estimate of Oct 15, 2026 to Oct 20, 2026
- Minor: Improving Outcomes Assessment in Chronic GVHD Study completion pushed from Feb 2027 to Feb 2028
- Minor: Quit2Heal Smartphone App in Helping Cancer Patients Quit Smoking Trial completed
- Minor: Patient Navigation and the Planning Advance Care Together Website to Improve Goals of Care Conversations in Hematopoietic Cell Transplant Survivors, IMPACT-HCT Trial Primary completion pushed from Sep 30, 2026 to Feb 28, 2027
- Notable: Use of One Or Two Probes for Thermal Ablation Among Screen Positive Women Living With HIV in C1001P-CS2 Kenya Recruitment opened
- Notable: One vs Two Probes for Thermal Ablation Among Cervical Cancer Screen Positive WLWH in C1001P-CS9 South Africa Recruitment opened
- Notable: Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant · Acute Leukemia or Myelodysplastic Syndrome (MDS) Primary completion pushed from Dec 31, 2027 to Dec 31, 2028
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates
New trial filings, last 30 days
| First posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-11-02 | NCT07908407 Remote Screening and Navigation to Increase Trial Enrollment, INVITE Trial | Not Yet Recruiting | |
| 2026-10-21 | NCT07887061 Tacabrutideg and Sonrotoclax, With Response-Guided Obinutuzumab, for the Treatment of… | Phase 2 | Not Yet Recruiting |
Active trials by phase
| Phase 1 | 11 | |
| Phase 1/2 | 9 | |
| Phase 2 | 30 | |
| Phase 3 | 1 |
Not charted: 45 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).
Disease areas by active trials, top 10 of 31
Leukemia (21) · Acute Myeloid Leukemia (AML) (15) · Myelodysplastic Syndromes (MDS) (14) · Acute Lymphoblastic Leukemia (ALL) (9) · MDS/MPN Overlap (9) · Lung Cancer (8) · Prostate Cancer (8) · Non-Hodgkin Lymphoma (7) · Chronic Lymphocytic Leukemia (CLL) (6) · Chronic Myeloid Leukemia (CML) (5)
Get alerts when Fred Hutchinson Cancer Center's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.